bioZhena Corporation seeks capital - medical devices for women
and their physicians, reproductive management, automatic cancer screen
bioZhena seeks financing to manufacture the first batch of our first OTC marketable
product within 7 months, the first milestone towards market dominance in scientific family
planningâ„¢ and in women's health monitoring. Prototype already FDA certified.
Minimum Angel Investment: $250,000. Est. ROI: 100%+ (5x investment). Duration:
Approx. 3 Years. Depending on your investment size and on your interest in the structure
of the deal, we can agree to pay back your invested cash via profit sharing while you keep
your shares of stock - if you become the first investor(s) in our Private Placement Offering
(open to up to 12 accredited investors).
The enterprise involves an electronic OTC device technology developed to make it possible
that every pregnancy is deliberate, and to impact on women's healthcare and public health
in other ways, too.
Personal self-diagnostic device will tell the woman in plain English (or Chinese, Arabic,
Hindi, Spanish, etc.) whether today is one of the 3 days that she can become pregnant. A 3-
day window, unless stress causes delayed ovulation or suppresses it completely, which is
then detected.
Far more than a tool to aid achieving pregnancy
Cervical cancer screening automatically going on in the background; and with other uses
(such as early pregnancy detection; data-based forecast of the EDD, Estimated Date of
Delivery; management of PMS/PMDD; managementof hormone therapy, to mention a few
-- and not to mention fetal sex pre-selection, which our customers will almost certainly
try!).
The Ovulonaâ„¢ device generates and makes available to physicians data on menstrual
cyclic profiles (folliculogenesis), a new means of patient profiling - from post-adolescence
to peri-menopause. A related product line for physicians ensues - enables correlation of
symptoms, and treatment, with folliculogenesis. Key concepts: personalized medicine,
telemedicine, medicine depends on diag nostic tools.
Anyone who can contribute to the commercialization of this technology, please get in
touch, particularly you, the investor. Please review the info referenced below first, and
email me at: vaclavkirsner@yahoo.com . Further particulars will be provided upon request.
In re: the birth control use of the bioZhena core technology. Approximately one-half of
pregnancies in the United States are unintended (at an estimated cost to the economy that is
comparable to the cost of cancer care), and the United States has set a national goal of
bioZhena Corporation
83 Davis Ranch Road, P.O. Box 122, Bellvue, Colorado 80512, USA
Vaclav Kirsner, Ph.D., Chairman and CEO
vaclavkirsner@yahoo.com
970-484-1272

decreasing unintended pregnancies to 30% by 2010. 76 percent occur to adult women over
the age of 20. Unplanned pregnancies happen to womenof all ages, backgrounds,
education, income levels, and in every workforce.
There is no other product like ours out there, and our technology can make a
significant difference. We will revolutionize women's healthcare.
http://www.linkedin.com/in/vaclavkirsner - Vaclav is working on capital formation for
bioZhena Corporation
http://biozhena.wordpress.com - see \"This is not another ovulation kit, my dear\"
http://biozhena.wordpress.com/2007 /12/10/biozhenas-mission-a-health-tool-for-every-
woman - Our OTC product will empower women everywhere
http://www.perfectbusiness.com/vaclavkirsner - see BUSINESS tab for exec summary
profile
P.S.
The folliculogenesis-tracking technology with a customer-friendly user interface resulted
from a unique synergy of biomedical insight, physical science, and a need-driven quest for
a solution. The folliculogenesis-tracking technology would not have arisen had it not been
for those three ingredients coming together: the motivating need (to overcome apparent
infertility), the physical science (electrochemistry in particular), and the biological insight,
nourished by pharmaceutical R&D practice of interdisciplinary combination of life science
and physical science principles.
Folliculogenesis is a fairly esoteric biomedical subject, of interest to specialized biological
and medical scientists. To make an understatement, you will not find many, if any, physical
scientists or technologists working with it. People who work with folliculogenesis do so
invariably to manipulate the female organism either to chemically interfere with or to
chemically aid the occurrence of ovulation - that is to prevent or to enhance the chances of
conception, respectively. We do not. We do not interfere, we merely detect and diagnose.
We use the in vivo tracking of folliculogenesis as a handle for, a window on, reproductive
health. This is because women's health revolves around the menstrual cycle, that is,
folliculogenesis, so we have a handle on other things, too.
To the future women users anywhere in the world: There is no other technology that
would - automatically and without bothering you at all - keep track of whether your
cervical tissues are healthy, and would issue a warning only when detecting tissue
aberration several months in a row (to spare you the anxieties and expenses associated
with the Pap smear cervical cancer tests' false positives).
bioZhena Corporation
83 Davis Ranch Road, P.O. Box 122, Bellvue, Colorado 80512, USA
Vaclav Kirsner, Ph.D., Chairman and CEO
vaclavkirsner@yahoo.com
970-484-1272

http://biozhena.files.wordpress.com/2008/10/ovulona-fertile-window-vs-old-method1.jpg
There is no device in the marketplace that would tell you, in plain English or any other
language, \"today is your fertile day 1\" - meaning that sex today is likely to lead to
pregnancy. And from our clinical trial results you will know that the pregnancy
conceived on this first of the fertile days is likely to be a male fetus, a boy.
http://biozhena.files.wordpress.com/2007/12/ovulonatm-from-ppp-biozhena-6-10-04.jpg?w=300
For more about this, do go to the bioZhena weblog http://biozhena.wordpress.com
\"There is no technology as yet available to all women worldwide with all these
empowering features at a perfectly affordable cost.\"
bioZhena Corporation
83 Davis Ranch Road, P.O. Box 122, Bellvue, Colorado 80512, USA
Vaclav Kirsner, Ph.D., Chairman and CEO
vaclavkirsner@yahoo.com
970-484-1272